This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Watson, S. A. Articles by Smith, A. M. Search for Related Content PubMed PubMed Citation Articles by Watson, S. A. Articles by Smith, A. M.

Hypergastrinemia Promotes Adenoma Progression in the APC^Min-/+ Mouse Model of Familial Adenomatous Polyposis¹

Academic Unit of Cancer Studies, Department of Surgery, University of Nottingham, Nottingham NG7 2UH, United Kingdom

Serum hypergastrinemia promotes the growth of colorectal adenocarcinoma. Some colorectal adenomas express cholecystokinin B/gastrin receptor mRNA, and thus hypergastrinemia may increase progression through the adenoma-carcinoma sequence. This was investigated in the multiple intestinal neoplasia APC^Min-/+ mouse. Serum gastrin levels in APC^Min-/+ mice were elevated 5–6-fold by oral administration of omeprazole (75 mg/kg). Terminal tumor burden was monitored by onset of anemia. A labeling index was generated by immunohistochemical detection of bromodeoxyuridine incorporation. Serum gastrin was neutralized by antigastrin antibodies raised in situ by use of a gastrin immunogen, Gastrimmune. Hypergastrinemia resulted in reduced survival of the APC^Min-/+ mice from a median survival of 13 weeks in the controls to 10 weeks following omeprazole treatment (P < 0.00001, log-rank test). The labeling indices of adenomas from the small and large intestines of omeprazole-treated mice were increased 35 and 29%, respectively (P < 0.05 and P < 0.025, respectively). Gastrimmune immunization reversed both the survival effect and the increased proliferation resulting from serum hypergastrinemia. Hypergastrinemia may promote the progression of existing premalignant colonic lesions by increasing proliferation. Clinical investigations should determine whether this occurs in the human scenario, considering the widespread use of proton pump inhibitors.

This article has been cited by other articles:

				T. K. Roepke, A. Anantharam, P. Kirchhoff, S. M. Busque, J. B. Young, J. P. Geibel, D. J. Lerner, and G. W. Abbott The KCNE2 Potassium Channel Ancillary Subunit Is Essential for Gastric Acid Secretion J. Biol. Chem., August 18, 2006; 281(33): 23740 - 23747. [Abstract] [Full Text] [PDF]

				J. H. Dickson, A. Grabowska, M. El-Zaatari, J. Atherton, and S. A. Watson Helicobacter pylori Can Induce Heparin-Binding Epidermal Growth Factor Expression via Gastrin and Its Receptor. Cancer Res., August 1, 2006; 66(15): 7524 - 7531. [Abstract] [Full Text] [PDF]

				F. Hollande, A. Shulkes, and G. S. Baldwin Signaling the Junctions in Gut Epithelium Sci. Signal., March 29, 2005; 2005(277): pe13 - pe13. [Abstract] [Full Text] [PDF]

				P. D. Ottewell, A. Varro, G. J. Dockray, C. M. Kirton, A. J. M. Watson, T. C. Wang, R. Dimaline, and D. M. Pritchard COOH-terminal 26-amino acid residues of progastrin are sufficient for stimulation of mitosis in murine colonic epithelium in vivo Am J Physiol Gastrointest Liver Physiol, March 1, 2005; 288(3): G541 - G549. [Abstract] [Full Text] [PDF]

				F. Luciani, M. Spada, A. De Milito, A. Molinari, L. Rivoltini, A. Montinaro, M. Marra, L. Lugini, M. Logozzi, F. Lozupone, et al. Effect of Proton Pump Inhibitor Pretreatment on Resistance of Solid Tumors to Cytotoxic Drugs J Natl Cancer Inst, November 17, 2004; 96(22): 1702 - 1713. [Abstract] [Full Text] [PDF]

				S. Lei, A. Dubeykovskiy, A. Chakladar, L. Wojtukiewicz, and T. C. Wang The Murine Gastrin Promoter Is Synergistically Activated by Transforming Growth Factor-{beta}/Smad and Wnt Signaling Pathways J. Biol. Chem., October 8, 2004; 279(41): 42492 - 42502. [Abstract] [Full Text] [PDF]

				J. C. Harris, A. D. Gilliam, A. J. McKenzie, S. A. Evans, A. M. Grabowska, P. A. Clarke, D. F. McWilliams, and S. A. Watson The Biological and Therapeutic Importance of Gastrin Gene Expression in Pancreatic Adenocarcinomas Cancer Res., August 15, 2004; 64(16): 5624 - 5631. [Abstract] [Full Text] [PDF]